Asia Digest: Japan's GINKAN raises $2.6m; SK Group buys 25% stake in Imexpharm

Japan’s GINKAN Inc has raised a $2.6 million Series A funding round led by MTG Ventures, Inc while South Korean chaebol SK Group has acquired a 25 per cent stake in Vietnam’s Imexpharm Corporation.